0.401
Beyond Air Inc stock is traded at $0.401, with a volume of 258.59K.
It is down -0.25% in the last 24 hours and down -25.66% over the past month.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
See More
Previous Close:
$0.402
Open:
$0.425
24h Volume:
258.59K
Relative Volume:
0.94
Market Cap:
$5.09M
Revenue:
$6.92M
Net Income/Loss:
$-32.03M
P/E Ratio:
-0.074
EPS:
-5.4201
Net Cash Flow:
$-22.13M
1W Performance:
-19.46%
1M Performance:
-25.66%
6M Performance:
-69.39%
1Y Performance:
+112.73%
Beyond Air Inc Stock (XAIR) Company Profile
Name
Beyond Air Inc
Sector
Industry
Phone
516-665-8200
Address
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
XAIR
Beyond Air Inc
|
0.401 | 5.10M | 6.92M | -32.03M | -22.13M | -5.4201 |
|
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | D. Boral Capital | Buy |
| Jun-25-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-28-23 | Initiated | Piper Sandler | Overweight |
| Jun-15-23 | Initiated | BTIG Research | Buy |
| Apr-28-21 | Initiated | Truist | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Outperform |
View All
Beyond Air Inc Stock (XAIR) Latest News
Beyond Air Inc. (XAIR) Q1 2026 Earnings: Narrowed Loss Slightly Exceeds Expectations as Clinical Pipeline AdvancesEBITDA Estimate Trend - Newser
Beyond Air Inc. (XAIR) Q1 2026 Earnings: Narrowing Losses but Revenue Remains AbsentAnalyst Drop Coverage - Newser
Beyond Air Inc. (XAIR) Holds Near Flatline as Stock Tests Key Support ZoneOpen Market Insights - Newser
Beyond Air (XAIR) Q1 2026 Earnings: EPS $-0.83 Beats EstimatesSocial Buy Zones - newser.com
XAIR Technical Analysis | Trend, Signals & Chart Patterns | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
Alyeska (XAIR) files 13G/A — reports zero beneficial ownership (amendment) - Stock Titan
Balyasny Group (NASDAQ: XAIR) reports 7.25% position in Beyond Air - Stock Titan
XAIR Stock Price, Quote & Chart | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
TradingKey - tradingkey.com
Lucid, Beyond Air, Conagra stocks hit 52-week lows: What's behind the drag? - MSN
XAIR (Beyond Air) shares tumble 12% despite 220% revenue surge, puzzling analysts on earnings day.Expansion Phase - newser.com
Beyond Air | DEF 14A: Definitive information statements - Moomoo
XAIR (Beyond Air) matches Q1 2026 analyst EPS estimates, shares fall 1.79 percent on muted investor sentiment. - Newser
D. Boral Capital Maintains Beyond Air (XAIR) Buy Recommendation - MSN
Beyond Air Q2 2026 Earnings Preview - MSN
Beyond Air (NASDAQ: XAIR) seeks approval for 1-for-2 to 1-for-20 reverse split to address $1 bid rule - Stock Titan
Beyond Air registers 719,561 shares for potential resale by warrant holders - MSN
XAIR (Beyond Air) Q1 2026 revenue surges 219.7 percent year over year, shares jump 4.68 percent. - Newser
Beyond Air (XAIR) Market Position | Q1 2026: Profit SurprisesOpen Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Beyond Air (XAIR) Stock: Trend Strength (Touches High) 2026-04-20Hot Community Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Beyond Air (XAIR) Reports Promising Data from Phase 1 Clinical T - GuruFocus
Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 - The Manila Times
After UNO tumor injection, 6 of 10 heavily treated patients remain alive - Stock Titan
Beyond Air | 8-K: Current report - Moomoo
Lucid, Beyond Air, and Conagra Shares Hit New Lows Amid Weak Guidance - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
XAIR (Beyond Air Inc.) reports 219.7 percent year over year Q1 revenue growth, but shares drop 11.71 percent today.Stock Analysis Community - Newser
Lucid, Beyond Air, Conagra Stocks Hit 52-Week Lows: What's Behind The Drag? - Stocktwits
Beyond Air Appeals Nasdaq Notice on Listing Compliance - TipRanks
Beyond Air (NASDAQ: XAIR) appeals Nasdaq $1 bid-price noncompliance in May hearing - Stock Titan
Beyond Air to Participate in the D. Boral Capital Global Conference 2026 - The Manila Times
Trend Review: Can Beyond Air Inc deliver consistent EPS growth2026 Reactions & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Gains Report: Can Beyond Air Inc outperform under higher oil prices2026 Technical Overview & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
RSI Check: Is Beyond Air Inc affected by consumer sentimentMarket Weekly Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
D. Boral Capital Initiates Coverage of Beyond Air (XAIR) with Buy Recommendation - MSN
Market Pulse: Can Beyond Air Inc outperform under higher oil pricesTrade Exit Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Is Beyond Air Inc affected by consumer sentiment2026 Major Catalysts & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Price Action: Can Beyond Air Inc deliver consistent EPS growth2026 Historical Comparison & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Beyond Air, Inc. Receives Nasdaq Delisting Notice and Considers Reverse Stock Split to Regain Compliance - Minichart
Beyond Air Inc Stock (XAIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):